Webcast Alert: Executives from Aastrom Biosciences, BioCryst Pharmaceuticals, Dendreon, Genentech and Spectrum Pharmaceuticals W

Webcast Alert: Executives from Aastrom Biosciences, BioCryst Pharmaceuticals,
Dendreon, Genentech and Spectrum Pharmaceuticals Will Present at Informed
Investors Biotech/Cancer Stocks Forum to be Webcast on Tuesday, December 16,
2003, 9 AM ET 


SAN FRANCISCO, Dec. 12  /PRNewswire/ -- Informed Investors will webcast the
following presentations:

  What:    Aastrom Biosciences, Inc. (NASDAQ:ASTM), BioCryst
           Pharmaceuticals, Inc. (NASDAQ:BCRX), Dendreon Corp.
           (NASDAQ:DNDN), Genentech (NYSE:DNA), and Spectrum
           Pharmaceuticals, Inc. (NASDAQ:SPPI) will give presentations at
           Informed Investors Biotech/Cancer Stocks Forum

  When:    December 16, 2003 @ 9:00 AM Eastern Time

  Where:   http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=296

  How:     Live over the Internet -- Simply log on to the web at the address
           above.

  Contacts:
  Aastrom Biosciences -- Investor Relations, 734-930-5777, 
  BioCryst Pharmaceuticals -- Michael A. Darwin, 205-444-4600,
   
  Dendreon -- Julie Rathbun, Investor Relations, [phone]
  Genentech -- Diane Schrick, 650-225-1599, 
  Spectrum Pharmaceuticals -- Anna Kazanchy, 



If you are unable to participate during the live webcast, the call will be
available for replay at
http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=296.

Aastrom Biosciences, Inc. is a late-stage development company focused on human
cell-based therapies.

BioCryst Pharmaceuticals, Inc. designs and develops novel drugs that block key
enzymes essential to disease progression.

Dendreon Corporation is a biotechnology company developing targeted therapies
for cancer.

Genentech is a leading biotechnology company that discovers, develops,
manufactures and commercializes biotherapeutics for significant unmet medical
needs.

Spectrum Pharmaceuticals' primary focus is to develop in-licensed drugs for the
treatment and supportive care of cancer patients.

FORUM CONTACT:  Janet Scharr, Informed Investors, 804-327-3424,  

Corp.; Genentech; Spectrum Pharmaceuticals Inc.

DATASOURCE: Aastrom Biosciences Inc.; BioCryst Pharmaceuticals, Inc.; Dendreon



CONTACT:  Aastrom Biosciences Investor Relations, [phone],

; Michael A. Darwin of BioCryst Pharmaceuticals,

[phone], ; Julie Rathbun, Investor Relations, of

Dendreon, [phone]; Diane Schrick of Genentech, [phone],

; or Anna Kazanchy of Spectrum Pharmaceuticals,

; FORUM CONTACT:  Janet Scharr of Informed Investors,

[phone], 



Web site:  http://www.informedinvestors.com/

Copyright